Variant report
Variant | esv3372348 |
---|---|
Chromosome Location | chr11:74112954-74114802 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr11:74114001-74114035 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr11:74113071-74113138 | Fibrobl | skin: | n/a | n/a |
3 | CTCF | chr11:74114455-74114525 | Spleen_OC | spleen: | n/a | n/a |
4 | JUN | chr11:74113288-74113394 | K562 | blood: | n/a | n/a |
5 | MXI1 | chr11:74114465-74115210 | SK-N-SH | brain: | n/a | n/a |
6 | MYC | chr11:74114027-74114082 | MCF-7 | breast: | n/a | n/a |
7 | MYC | chr11:74114041-74114072 | MCF-7 | breast: | n/a | n/a |
8 | POLR2A | chr11:74114080-74114120 | A549 | lung: | n/a | n/a |
9 | POLR2A | chr11:74112861-74112954 | GM12878 | blood: | n/a | n/a |
10 | POLR2A | chr11:74114526-74114558 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | POLR2A | chr11:74114056-74114077 | A549 | lung: | n/a | n/a |
12 | POLR2A | chr11:74113960-74114130 | MCF-7 | breast: | n/a | n/a |
13 | ZNF274 | chr11:74113220-74113857 | K562 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:74113820..74116685-chr11:74117117..74119605,4 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PGM2L1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186467678 | chr11:74113028-74113029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs374201283 | chr11:74113054-74113055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143990458 | chr11:74113110-74113111 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs35482615 | chr11:74113153-74113154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs145944794 | chr11:74113181-74113182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs200947959 | chr11:74113182-74113183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12417530 | chr11:74113183-74113184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572483627 | chr11:74113191-74113192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12418456 | chr11:74113193-74113194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147287709 | chr11:74113199-74113200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12417532 | chr11:74113201-74113202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs186923933 | chr11:74113209-74113210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12417535 | chr11:74113221-74113222 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs12417253 | chr11:74113222-74113223 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs533732786 | chr11:74113229-74113230 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs547611462 | chr11:74113241-74113242 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs12417254 | chr11:74113242-74113243 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs12417537 | chr11:74113243-74113244 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs12278437 | chr11:74113266-74113267 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs12417265 | chr11:74113279-74113280 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs12417552 | chr11:74113285-74113286 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs12417266 | chr11:74113286-74113287 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs539897268 | chr11:74113304-74113305 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs12417553 | chr11:74113325-74113326 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs12417554 | chr11:74113363-74113364 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs12417271 | chr11:74113366-74113367 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs149239764 | chr11:74113371-74113372 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs12417564 | chr11:74113384-74113385 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs12417276 | chr11:74113385-74113386 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs35605186 | chr11:74113387-74113388 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs556703607 | chr11:74113389-74113390 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs570032006 | chr11:74113390-74113391 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs535871975 | chr11:74113400-74113401 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs111219002 | chr11:74113421-74113422 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs183464816 | chr11:74113430-74113431 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs541301148 | chr11:74113434-74113435 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs564664781 | chr11:74113446-74113447 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs555762235 | chr11:74113494-74113495 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs578250328 | chr11:74113556-74113557 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs201779545 | chr11:74113575-74113576 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs140066143 | chr11:74113582-74113583 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs10898985 | chr11:74113604-74113605 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs562485725 | chr11:74113631-74113632 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs531182409 | chr11:74113640-74113641 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs541790298 | chr11:74113644-74113645 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs11236097 | chr11:74113667-74113668 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs138127109 | chr11:74113766-74113767 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs547237026 | chr11:74113781-74113782 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs541254121 | chr11:74113828-74113829 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs112327043 | chr11:74113855-74113856 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 21364760 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:74110400-74113400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr11:74110400-74114400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr11:74110600-74114400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr11:74110600-74114600 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
5 | chr11:74110800-74114400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr11:74110800-74114800 | Weak transcription | K562 | blood |
7 | chr11:74110800-74118400 | Weak transcription | Pancreas | Pancrea |
8 | chr11:74112200-74114400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
9 | chr11:74112400-74114800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr11:74112600-74114800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr11:74113600-74114800 | Weak transcription | Fetal Thymus | thymus |
12 | chr11:74114400-74114600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
13 | chr11:74114400-74115200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr11:74114400-74115400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr11:74114600-74115200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
16 | chr11:74114600-74115400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
17 | chr11:74114800-74115000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
18 | chr11:74114800-74115200 | Enhancers | K562 | blood |
19 | chr11:74114800-74115400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
20 | chr11:74114800-74115400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
21 | chr11:74114800-74115600 | Enhancers | Fetal Thymus | thymus |